Research design
opioid use disorder
This study was a randomized, single-blind, parallel, two-arm clinical trial on patients with opioid use disorder receiving MMT in an addiction treatment clinic in an urban area of ​​Iran from April 2021, lasting three months. The research protocol was also listed on the Iranian Registry of Clinical Trials (IRCT) with code no. IRCT2020050904736N1.